Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Adenocarcinoma and CHI3L2[original query] |
---|
Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants. JAMA surgery 2019 Apr e190484. Dimitrakopoulos Christos, Vrugt Bart, Flury Renata, Schraml Peter, Knippschild Uwe, Wild Peter, Hoerstrup Simon, Henne-Bruns Doris, Wuerl Peter, Graf Rolf, Breitenstein Stefan, Bond Gareth, Beerenwinkel Niko, Grochola Lukasz Fil |
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival. Scientific reports 2021 Apr 11 (1): 7570. Gentiluomo Manuel, Corradi Chiara, Vanella Giuseppe, Johansen Astrid Z, Strobel Oliver, Szentesi Andrea, Milanetto Anna Caterina, Hegyi Péter, Kupcinskas Juozas, Tavano Francesca, Neoptolemos John P, Bozzato Dania, Hackert Thilo, Pezzilli Raffaele, Johansen Julia S, Costello Eithne, Mohelnikova-Duchonova Beatrice, van Eijck Casper H J, Talar-Wojnarowska Renata, Hansen Carsten Palnæs, Darvasi Erika, Chen Inna M, Cavestro Giulia Martina, Soucek Pavel, Piredda Liliana, Vodicka Pavel, Gazouli Maria, Arcidiacono Paolo Giorgio, Canzian Federico, Campa Daniele, Capurso Gabrie |
A predictive non-invasive SNP-based biomarker signature in resectable pancreatic cancer: protocol for a prospective validation study. JMIR research protocols 2024 4 . Nico Seeger, Stefan Gutknecht, Irin Zschokke, Isabella Fleischmann, Nadja Roth, Jürg Metzger, Markus Weber, Stefan Breitenstein, Lukasz Filip Grocho |
- Page last reviewed:Feb 1, 2024
- Content source: